According to the drug price regulator, the moving annual turnover (MAT) for consumers on formulations for which the new prices have been finalised until the end of March 2023 is estimated to have decreased by over Rs. 3,500 crore annually…
Tag: DPOC
In order to determine the ceiling prices for these scheduled formulations under the 2013 revision to Schedule I of the Drugs (Prices Control) Order (DPCO), the National Pharmaceutical Pricing Authority (NPPA) has requested the industry to provide the Price To…
